Fink E, Schleuning M
Hoppe Seylers Z Physiol Chem. 1982 Nov;363(11):1331-9. doi: 10.1515/bchm2.1982.363.2.1331.
Enzymatically active or diisopropyl fluorophosphate-inactivated pig pancreatic kallikrein were infused intravenously into dogs. Pig pancreatic kallikrein in plasma and urine was measured by a radioimmunoassay. The total excreted pig pancreatic kallikrein was 0.8-3.1% of the administered dose when active kallikrein was infused and 21.6% when inactive kallikrein was infused. The renal clearance of the administered kallikrein was found to be between 0.9 and 4.1 ml/min, which corresponds to 2.4-6.4% of the inulin or creatinine clearance. These results indicate that renal synthesis of tissue kallikrein and its direct secretion into the urine is not the exclusive mechanism of the excretion of tissue kallikrein into the urine. A second mechanism, the renal transfer of endogenous tissue kallikrein from the blood into the urine, can also contribute to the total amount of excreted urinary kallikrein.
将具有酶活性或经二异丙基氟磷酸酯灭活的猪胰激肽释放酶静脉注射到狗体内。采用放射免疫分析法测定血浆和尿液中的猪胰激肽释放酶。当注入活性激肽释放酶时,猪胰激肽释放酶的总排泄量为给药剂量的0.8 - 3.1%;当注入非活性激肽释放酶时,总排泄量为21.6%。所注入激肽释放酶的肾清除率为0.9至4.1毫升/分钟,相当于菊粉或肌酐清除率的2.4 - 6.4%。这些结果表明,肾脏合成组织激肽释放酶并将其直接分泌到尿液中并非组织激肽释放酶排泄到尿液中的唯一机制。另一种机制,即内源性组织激肽释放酶从血液向尿液的肾脏转运,也可导致尿激肽释放酶的总排泄量增加。